Full Text View
Tabular View
No Study Results Posted
Related Studies
DCVax Plus Poly ICLC in Healthy Volunteers
This study is ongoing, but not recruiting participants.
Study NCT01127464   Information provided by Rockefeller University

First Received on May 19, 2010.   Last Updated on February 28, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV-1 Infection
HIV Infection
Healthy Volunteers
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
HIV Infections
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
DCVax-001
Poly-ICLC
Placebo
Additional drug interventions recognized in this trial
Poly ICLC
More general drug interventions related to this trial
Immunologic Factors
Interferon Inducers
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Rockefeller University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services